$100K — $150K *
Evelo Biosciences is seeking an experienced and talented Associate Director of Corporate Communications to join our dynamic organization.
Evelo Biosciences (Nasdaq: EVLO) a biotechnology company developing a new modality of orally delivered, systemically acting biologics that could disrupt the industry, is looking for a highly motivated individual who is energized by the prospect of working in a clinical stage company, has a strong desire to learn, and wishes to be an integral member of growing team.
We are seeking a smart, creative, and collaborative Associate Director to join the Corporate Communications team. This role will work with the Vice President of Corporate Communications in developing and executing the overall (internal and external) corporate communications strategy, while also supporting other corporate initiatives.
This role offers the right candidate an exceptional opportunity to work on highly visible initiatives for a rapidly expanding organization. With numerous clinical readouts anticipated over the next 6-12 months, Evelo is currently in one of the most exciting periods in its history. This is a time of dynamic growth, requiring the development and execution of strategic communications to internal and external stakeholders.
Success in this role will be demonstrated by helping to develop and execute a comprehensive, best-in-class Communications program, that aligns with company strategy and leverages a strong understanding of the investment, biotech, and pharmaceutical communities to enhance the perception and visibility of Evelo.
Areas of Responsibility
Education, Experience, & Skills Required: We are looking for a truly outstanding individual that is excited to drive meaningful change. Below are key skills and experiences that we believe will lead to success in this role:
About Evelo Biosciences
Evelo Biosciences is a clinical stage biotechnology company developing oral biologics that act on SINTAX™, the small intestinal axis, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic and neurological systems. The company’s first product candidates are pharmaceutical preparations of single strains of microbes selected for defined pharmacological properties. Evelo’s therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people with inflammatory diseases and cancer.
Valid through: 11/19/2021
$80K — $100K *
9 days ago